NASDAQ:LGND - Ligand Pharmaceuticals Price Target & Analyst Ratings

$113.55
-1.33 (-1.16 %)
(As of 07/19/2019 04:00 PM ET)
Today's Range
$113.53
Now: $113.55
$116.50
50-Day Range
$106.96
MA: $113.39
$119.60
52-Week Range
$98.56
Now: $113.55
$278.62
Volume207,600 shs
Average Volume338,264 shs
Market Capitalization$2.23 billion
P/E Ratio18.71
Dividend YieldN/A
Beta1.38

Analyst Ratings

Ligand Pharmaceuticals (NASDAQ:LGND) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
7 Wall Street analysts have issued ratings and price targets for Ligand Pharmaceuticals in the last 12 months. Their average twelve-month price target is $204.1429, suggesting that the stock has a possible upside of 79.78%. The high price target for LGND is $260.00 and the low price target for LGND is $131.00. There are currently 2 hold ratings and 5 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.712.712.832.83
Ratings Breakdown: 0 Sell Rating(s)
2 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $204.1429$204.1429$224.6667$256.6667
Price Target Upside: 79.78% upside89.67% upside98.21% upside66.17% upside

Ligand Pharmaceuticals (NASDAQ:LGND) Consensus Price Target History

Ligand Pharmaceuticals (NASDAQ:LGND) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
6/11/2019BarclaysInitiated CoverageEqual Weight ➝ Equal Weight$131.00HighView Rating Details
6/10/2019ArgusSet Price TargetBuy$140.00MediumView Rating Details
5/3/2019HC WainwrightReiterated RatingBuy ➝ Buy$254.00 ➝ $214.00HighView Rating Details
3/7/2019Roth CapitalLower Price TargetBuy$195.00 ➝ $180.00LowView Rating Details
8/17/2018Goldman Sachs GroupInitiated CoverageNeutral$256.00HighView Rating Details
8/8/2018StephensReiterated RatingBuy$248.00HighView Rating Details
8/7/2018Craig HallumBoost Price TargetBuy$230.00 ➝ $260.00MediumView Rating Details
11/20/2017Deutsche BankDowngradeHold ➝ Sell$105.00N/AView Rating Details
(Data available from 7/20/2017 forward)
This page was last updated on 7/20/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel